ATE470669T1 - D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere - Google Patents

D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere

Info

Publication number
ATE470669T1
ATE470669T1 AT04730317T AT04730317T ATE470669T1 AT E470669 T1 ATE470669 T1 AT E470669T1 AT 04730317 T AT04730317 T AT 04730317T AT 04730317 T AT04730317 T AT 04730317T AT E470669 T1 ATE470669 T1 AT E470669T1
Authority
AT
Austria
Prior art keywords
pure
isomers
dinorpregn
17alpha
yne
Prior art date
Application number
AT04730317T
Other languages
English (en)
Inventor
Zoltan Tuba
Sandor Maho
Gyoergy Keseru
Jozsef Kozma
Janos Horvath
Gabor Balogh
Original Assignee
Richter Gedeon Nyrt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt
Application granted granted Critical
Publication of ATE470669T1 publication Critical patent/ATE470669T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
AT04730317T 2003-06-30 2004-04-29 D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere ATE470669T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0301981A HUP0301981A2 (hu) 2003-06-30 2003-06-30 Tiszta d-(17alfa)-13-etil-17-hidroxi-18,19-dinor-pregn-4-én-20-in-3-on-3E- és 3Z-oxim izomerek, valamint eljárás az izomer keverékek és a tiszta izomerek előállítására
PCT/HU2004/000030 WO2005000867A1 (en) 2003-06-30 2004-04-29 PURE D-(17α)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-ENE-20-YNE-3-ONE-3E- AND -3Z-OXIME ISOMERS, AS WELL AS PROCESS FOR THE SYNTHESIS OF THE MIXTURE OF ISOMERS AND THE PURE ISOMERS

Publications (1)

Publication Number Publication Date
ATE470669T1 true ATE470669T1 (de) 2010-06-15

Family

ID=90001693

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04730317T ATE470669T1 (de) 2003-06-30 2004-04-29 D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere

Country Status (17)

Country Link
EP (1) EP1641812B1 (de)
JP (1) JP2007534617A (de)
CN (1) CN100497368C (de)
AT (1) ATE470669T1 (de)
AU (1) AU2004251117A1 (de)
BR (1) BRPI0411734A (de)
CA (1) CA2526305A1 (de)
DE (1) DE602004027629D1 (de)
EA (1) EA008174B1 (de)
HR (1) HRP20060040A2 (de)
HU (1) HUP0301981A2 (de)
MX (1) MXPA05012655A (de)
NO (1) NO20060456L (de)
NZ (1) NZ544481A (de)
RS (1) RS20050816A (de)
UA (1) UA85190C2 (de)
WO (1) WO2005000867A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6734277B2 (en) 2002-05-09 2004-05-11 General Electric Company Method of enhancing pit replication in optical disks
US7576226B2 (en) 2003-06-30 2009-08-18 Richter Gedeon Vegyeszeti Gyar Rt. Process of making isomers of norelgestromin and methods using the same
TW200621796A (en) * 2004-08-12 2006-07-01 Sicor Inc Process for the preparation of 3-oximino steroids
US9056061B2 (en) * 2005-09-23 2015-06-16 Alza Corporation Transdermal nicotine salt delivery system

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1123104A (en) * 1965-10-22 1968-08-14 Ortho Pharma Corp 3-oxime-steroids and method of preparation
CA1034942A (en) * 1973-03-01 1978-07-18 Ortho Pharmaceutical Corporation Steroidal oximes
US4027019A (en) * 1975-07-24 1977-05-31 Ortho Pharmaceutical Corporation 3-Oximes of D-17α-ethynyl-19-nortestosterone esters and method
JPS624400A (ja) * 1985-06-29 1987-01-10 内藤　喜之 マイクロ波用アンテナ
DE3888269T2 (de) * 1987-09-24 1994-07-07 Jencap Research Ltd Hormon-Zusammensetzung und -Anwendung.
CN1188189C (zh) * 1995-06-07 2005-02-09 奥瑟－麦内尔制药公司 基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途

Also Published As

Publication number Publication date
EP1641812A1 (de) 2006-04-05
UA85190C2 (en) 2009-01-12
EA200600120A1 (ru) 2006-06-30
EA008174B1 (ru) 2007-04-27
HRP20060040A2 (hr) 2007-08-31
EP1641812B1 (de) 2010-06-09
CN100497368C (zh) 2009-06-10
NZ544481A (en) 2009-05-31
AU2004251117A1 (en) 2005-01-06
CA2526305A1 (en) 2005-01-06
MXPA05012655A (es) 2006-02-22
HUP0301981D0 (en) 2003-09-29
NO20060456L (no) 2006-03-30
RS20050816A (sr) 2007-08-03
CN1798758A (zh) 2006-07-05
HUP0301981A2 (hu) 2005-04-28
BRPI0411734A (pt) 2006-08-08
WO2005000867A1 (en) 2005-01-06
DE602004027629D1 (de) 2010-07-22
JP2007534617A (ja) 2007-11-29

Similar Documents

Publication Publication Date Title
UA86063C2 (ru) Липосомы для снабжения лекарств
NO20051102L (no) Sulfonylamino-eddiksyre-derivater
WO2006003481A3 (en) Oleaginous pharmaceutical and cosmetic foam
SG146648A1 (en) Pharmaceutical compositions for treating premature ejaculation by pulmonary inhalation
HUP0104718A2 (hu) Mikronizált eplerenon kompozíciók és eljárás az előállításukra
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
BRPI0113286B8 (pt) pirazóis substituídos e composição farmacêutica compreendendo os mesmos.
SE0301010D0 (sv) Novel compounds
IS6658A (is) Ný efnasambönd
SE0301009D0 (sv) Novel compounds
BRPI0508579A (pt) composto, composição farmacêutica, e, uso de um composto
IL164974A0 (en) Novel compounds and their use
TW200514772A (en) Novel tetrahydropyridine derivatives
ATE430160T1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
BR0211739A (pt) Novas formas polimórficas cristalinas de cloridrato de lercanidipina e processo para preparação das mesmas
BR0316724A (pt) Compostos, uso de um ou mais compostos, e, processo para a fabricação de composições farmacêuticas
ATE470669T1 (de) D-(17alpha)-13-ethyl-17hydroxy-18,19-dinorpregn 4-ene-20-yne-3-one in form des reinen 3e- und 3z- oximes sowie das verfahren zur herstellung der mischung der isomere wie auch der reinen isomere
TNSN03065A1 (en) BIOPESTICIDE COMPOSITIONS
ATE428442T1 (de) Immuntherapeutikum für die kombinierte behandlung von tuberkulose mit anderen pharmazeutika
IL172358A0 (en) Colchicoside analogues
DE60102084D1 (de) Propanolaminotetraline, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende pharmazeutische zusammensetzungen
WO2003045971A3 (en) Solvates of 3.beta., 28-diacetoxy-18-oxo-19, 20, 21, 29, 30-pentanorlupan-22-oic acid, processes for their preparation and pharmaceutical compositions thereof
PL1668003T3 (pl) Benzoizoksazole
ATE275576T1 (de) Ungesättigte 14,15-cyclopropano-androstane, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzungen
TW200603812A (en) D-homo-17-chlor-16(17)-ene steroids

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties